Starpharma Holdings reported AUD26.17M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Medical Developments International AUD 63.57M 2.83M Dec/2025
Mesoblast USD 773.08M 9.23M Jun/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025